Link between circadian rhythm and benign prostatic hyperplasia (BPH)/lower urinary tract symptoms (LUTS)
- PMID: 38193363
- PMCID: PMC10922447
- DOI: 10.1002/pros.24656
Link between circadian rhythm and benign prostatic hyperplasia (BPH)/lower urinary tract symptoms (LUTS)
Abstract
Background: Benign prostatic hyperplasia (BPH) is the most common urologic disease in aging males, affecting 50% of men over 50 and up to 80% of men over 80 years old. Its negative impact on health-related quality of life implores further investigation into its risk factors and strategies for effective management. Although the exact molecular mechanisms underlying pathophysiological onset of BPH are poorly defined, the current hypothesized contributors to BPH and lower urinary tract symptoms (LUTS) include aging, inflammation, metabolic syndrome, and hormonal changes. These processes are indirectly influenced by circadian rhythm disruption. In this article, we review the recent evidence on the potential association of light changes/circadian rhythm disruption and the onset of BPH and impact on treatment.
Methods: A narrative literature review was conducted using PubMed and Google Scholar to identify supporting evidence. The articles referenced ranged from 1975 to 2023.
Results: A clear relationship between BPH/LUTS and circadian rhythm disruption is yet to be established. However, common mediators influence both diseases, including proinflammatory states, metabolic syndrome, and hormonal regulation that can be asserted to circadian disruption. Some studies have identified a possible relationship between general LUTS and sleep disturbance, but little research has been done on the medical management of these diseases and how circadian rhythm disruption further affects treatment outcomes.
Conclusions: There is evidence to implicate a relationship between BPH/LUTS and circadian rhythm disruptions. However, there is scarce literature on potential specific link in medical management of the disease and treatment outcomes with circadian rhythm disruption. Further study is warranted to provide BPH patients with insights into circadian rhythm directed appropriate interventions.
Keywords: benign prostate growth; benign prostatic hyperplasia; circadian rhythm disruption; light; lower urinary tract symptoms; racial disparities; risk factors; therapeutic management.
© 2023 Wiley Periodicals LLC.
Conflict of interest statement
Similar articles
-
Impact of metabolic syndrome-related factors on the development of benign prostatic hyperplasia and lower urinary tract symptoms in Asian population.Medicine (Baltimore). 2019 Oct;98(42):e17635. doi: 10.1097/MD.0000000000017635. Medicine (Baltimore). 2019. PMID: 31626149 Free PMC article.
-
Erectile Dysfunction and Lower Urinary Tract Symptoms.Eur Urol Focus. 2017 Oct;3(4-5):352-363. doi: 10.1016/j.euf.2017.11.004. Epub 2017 Nov 27. Eur Urol Focus. 2017. PMID: 29191671 Review.
-
The prostaglandin pathway is activated in patients who fail medical therapy for benign prostatic hyperplasia with lower urinary tract symptoms.Prostate. 2021 Sep;81(13):944-955. doi: 10.1002/pros.24190. Epub 2021 Jul 20. Prostate. 2021. PMID: 34288015 Free PMC article.
-
Burden of male lower urinary tract symptoms (LUTS) suggestive of benign prostatic hyperplasia (BPH) - focus on the UK.BJU Int. 2015 Apr;115(4):508-19. doi: 10.1111/bju.12745. Epub 2014 Oct 16. BJU Int. 2015. PMID: 24656222 Review.
-
Inflammation is a target of medical treatment for lower urinary tract symptoms associated with benign prostatic hyperplasia.World J Urol. 2020 Nov;38(11):2771-2779. doi: 10.1007/s00345-020-03106-1. Epub 2020 Feb 14. World J Urol. 2020. PMID: 32060633 Free PMC article. Review.
Cited by
-
Exploring the complex interplay: BPH, nocturia, and aging male health.World J Urol. 2024 Feb 26;42(1):105. doi: 10.1007/s00345-024-04849-x. World J Urol. 2024. PMID: 38407677 No abstract available.
References
-
- Collaborators GBDBPH. The global, regional, and national burden of benign prostatic hyperplasia in 204 countries and territories from 2000 to 2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet Healthy Longev. Nov 2022;3(11):e754–e776. doi:10.1016/S2666-7568(22)00213-6 - DOI - PMC - PubMed
-
- Russo GI, Urzì D, Cimino S. Chapter 1 - Epidemiology of LUTS and BPH. In: Morgia G, Russo GI, eds. Lower Urinary Tract Symptoms and Benign Prostatic Hyperplasia. Academic Press; 2018:1–14.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical